MAPT and early-onset autosomal dominant Alzheimer disease: Verelst et al. have examined the diagnostic potential of monoclonal antibody (mAb), the conformation ability, of which appeared to depend on the specificity to Tau insert, and found that the mAb can discriminate patients with Alzheimer’s disease from healthy individuals13.